Could Weight-Loss Drugs Help Get People Back to Work? The U.K. Wants to Find Out.
The British government announced a multimillion dollar pharmaceutical partnership with Eli Lilly, including a trial that will ...
FDA shakes up weight loss market as Mounjaro shortage ends
Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...
Mounjaro is more effective for weight loss than Ozempic—how does it work? And why does it cost so much?
,A weight-loss drug more effective than Ozempic and Wegovy has recently been approved in Australia. The drug, tirzepatide, is ...
UK's weight loss jab Mounjaro might help people get back to work: All about it
The UK government starts a trial offering weight loss drug Mounjaro to unemployed obese individuals to improve health and ...
Mounjaro: controversial weight loss injections proposed for UK unemployed to boost workforce - side effects
Nearly a quarter-of-a-million people are expected to receive the Mounjaro jab over the next three years. NHS officials have ...
Could weight-loss drugs boost the economy?
Weight-loss jabs could be used to help unemployed people get back to work, in a plan under consideration by Wes Streeting. Writing in The Telegraph, the health secretary said obesity was placing a ...
Health on MSN13h
What the End of a Tirzepatide Shortage Would Mean for Access to Compounded Weight Loss Drugs
In response to a lawsuit, the FDA has said that it will reevaluate its previous decision to remove tirzepatide from its ...
The Hill3d
FDA shakes up weight loss market as Mounjaro shortage ends
Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound were no longer in shortage after nearly two years. Pharmacies that sold unbranded ...
Ozempic or Mounjaro weight loss jabs to be given to obese unemployed people to help them into work
Health Secretary Wes Streeting has suggested that new weight loss injections such as Ozempic or Mounjaro could be given to ...
HealthDay on MSN16h
FDA Says Compounding Pharmacies Can Keep Making Weight-Loss Med Tirzepatide, for Now
On October 7, a compounding trade group filed a lawsuit challenging the agency's action, saying there was still a shortage of the wildly popular drug.